ÂÜÀòÂÒÂ×

Log inSign up

Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou
President & CEO

William Chou

Collapse
Mark Forman
Chief Medical Officer
JW
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
SA
Samiah Al-Zaidy
VP, Clinical Development
EF
Eden Fucci
VP, Manufacturing Operations
TV
Tiffini Voss
VP, Clinical Development
SH
Stuart Henderson
VP, Corporate Development & Investor Relations
Sue Browne
VP, Biology
Steve Krausert
Vice President, Supply Chain & Planning
AP
Anne Marie Pierce
Finance Operations Specialist
Patricia Elsasser
Director Clinical Operations
BL
Bin Lu
Senior Scientist, Gene Therapy Process And Product Development
Derek Kichula
Senior Director, Engineering & General Manager
Rich Mastropietro
Executive Director, IT
Rose Johnstone
Executive Director, Data Management
Karl Whitney
Senior Vice President, Global Regulatory Affairs
Chelsea Difebbo Ortiz
Executive Director, Patient Advocacy
GI
Glen Kerker II
Director, Regulatory Operations

Teams

+10

Leadership Team

13 members

+9

Scientific Research and Development

12 members

GI
+7

Clinical Operations and Quality Assurance

10 members

+3

Finance and Administrative Support

6 members

Similar companies

Kura Oncology

19 followers

REVOLUTION Medicines

5 followers

Summit Therapeutics

4 followers

Stemline Therapeutics

3 followers

Prime Medicine

3 followers

CytomX

3 followers

4D Molecular Therapeutics

3 followers

Kodiak

2 followers

EyePoint Pharmaceuticals

2 followers

Mersana Therapeutics

1 follower

ReCode Therapeutics

1 follower

Explore companies